Brent Suen
Chief Executive Officer at LOGIQ, INC.
Net worth: 998 177 $ as of 2024-03-30
Profile
Brent Y.
Suen is the founder of Bay2peak S A (founded in 2003), Elevation Capital (founded in 1997), Axis Trading Corp.
(founded in 1993), and Logiq, Inc. (founded in 2014).
At Logiq, Inc., he holds the title of Executive Chairman, President & CEO.
Currently, Mr. Suen is the Chairman at GoLogiq, Inc. (since 2021).
In the past, he worked as the Director of Strategic Development at SinoBiomed, Inc. (from 2008 to 2011) and as a Director at Collective Audience, Inc. (from 2023 to 2024).
Mr. Suen obtained his undergraduate degree from The University of Arkansas.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
7.84% | 2023-12-25 | 1,079,578 ( 7.84% ) | 675 816 $ | 2024-03-30 |
GOLOGIQ, INC.
1.68% | 2023-03-19 | 1,061,703 ( 1.68% ) | 317 449 $ | 2024-03-30 |
LOGIQ, INC.
0.36% | 2023-04-09 | 377,842 ( 0.36% ) | 4 912 $ | 2024-03-30 |
Brent Suen active positions
Companies | Position | Start |
---|---|---|
LOGIQ, INC. | Chief Executive Officer | 2022-01-06 |
GOLOGIQ, INC. | Chairman | 2021-11-25 |
Former positions of Brent Suen
Companies | Position | End |
---|---|---|
SinoBiomed, Inc.
SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Corporate Officer/Principal | 2011-08-03 |
Axis Trading Corp. | Founder | - |
Bay2peak S A | Founder | - |
Elevation Capital | Founder | - |
Training of Brent Suen
The University of Arkansas | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
LOGIQ, INC. | Technology Services |
Private companies | 5 |
---|---|
SinoBiomed, Inc.
SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Health Technology |
Bay2peak S A | |
Elevation Capital | |
GoLogiq, Inc. | |
Axis Trading Corp. |
- Stock Market
- Insiders
- Brent Suen